MedPath

Prospective validation of a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infectio

Conditions
U07.9
Registration Number
DRKS00022495
Lead Sponsor
Medizinische Hochschule Hannover HannoverClinical Trial Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1012
Inclusion Criteria

Covid-19 disease
Ability for informed consent

Exclusion Criteria

Anuria

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath